期刊文献+

诱骗受体3在子宫颈上皮内瘤变及子宫颈癌中的表达及临床意义 被引量:10

原文传递
导出
摘要 宫颈癌的发生、发展和常规治疗的预后与机体的免疫状态相关。宫颈上皮内瘤变(CIN)及宫颈癌的发病与肿瘤细胞的免疫应答紊乱有关,宫颈局部免疫活性细胞质和量的异常被认为在CIN和宫颈癌的发生中起着重要的作用。
出处 《中华妇产科杂志》 CAS CSCD 北大核心 2012年第2期150-152,共3页 Chinese Journal of Obstetrics and Gynecology
基金 基金项目:上海市浦东新区卫生系统医学领先人才培养计划(PWRd2008-5)
作者简介 通信作者:杨宾烈,Email:glyangbinlie@gmail.com
  • 相关文献

参考文献16

  • 1Gill RM, Ni J, Hunt JS. Differential expression of LIGHT and its receptors in human placental villi and amuiochorion membranes. Am J Pathol, 2002, 161:2011-2017.
  • 2Gill RM, Coleman NM, Hunt JS. Differential cellular expression of LIGHT and its receptors in early gestation human placentas. J Reprod Immunol, 2007, 74 : 1-6.
  • 3Connolly K, Cho YH, Duan R, et al. In vivo inhibition of Fas ligand-mediated killing by TR6, a Fas ligand decoy receptor. J Pharmacol Exp Ther, 2001, 298:25-33.
  • 4Pitti RM, Marsters SA, Lawrence DA, et al. Genomie amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature, 1998, 396:699-703.
  • 5Migone TS, Zhang J, Luo X, et al. TL1A is a TNF-like ligand for DR3 and TR6/DcR3 and functions as a T cell costimulator. Immunity, 2002, 16:479-492.
  • 6Hsu TL, Wu YY, Chang YC, et al. Attenuation of Thl response in decoy receptor 3 transgenic mice. J Immunol, 2005, 175: 5135-5145.
  • 7Zhang J, Salcedo TW, Wan X, et al. Modulation of T-cell responses to alloautigens by TR6/DcR3. J Clin Invest, 2001, 107 : 1459-1468.
  • 8Hsu M J, Lin WW, Tsao WC, et al. Enhanced adhesion of monocytes via reverse signaling triggered by decoy receptor 3. Exp Cell Res, 2004, 292 : 241-251.
  • 9Kim S, Fotiadu A, Kotoula V. Increased expression of soluble decoy receptor 3 in acutely inflamed intestinal epithelia. Clin Immunol, 2005, 115:286-294.
  • 10Chang YC, Hsu TL, Lin HH, et al. Modulation of macrophage differentiation and activation by decoy receptor 3. J Leukoc Biol, 2004, 75:486-494.

二级参考文献7

  • 1Pitti RM, Marsters SA, Lawrence DA, et al. Genomic amplification of a decoy receptor for Fas ligand in lung and colon cancer. Nature, 1998, 396: 699-703.
  • 2Bai C, Connolly B, Metzker ML, et al. Overexpression of M68/DcR3 in human gastro -intestinal tract tumors independent of gene amplification and its location in a four-gene cluster. Proc Natl Acad Sci USA, 2000, 97: 1230-1235. 3 Roth W, Isenmann S, Nakamura M, et al. Soluble decoy receptor
  • 3is expressed by malignant gliomas and suppresses CD95 ligand-induced apoptosis and chemotaxis. Cancer Research, 2001, 61:2759-2765.
  • 4Yu KY, Kwon B, Ni J, et al. A newly identified member of tumor necrosis factor receptor superfamily (TR6) suppresses LIGHT-mediated apoptosis. J Biol Chem,1999, 274, 13733 -13736.
  • 5Ohshima K, Haraoka S, Sugihara M, et al. Amplification and expression of a decoy receptor for fas ligand (DcR3) in virus (EBV or HTLV-I) associated lymphomas. Cancer Lett, 2000, 160:89-97.
  • 6Yasushi Takahama,Yukishige Yamada,Koji Emoto,Heisuke Fujimoto,Tomoyoshi Takayama,Masatoh Ueno,Hideki Uchida,Shuya Hirao,Takashi Mizuno,Yoshiyuki Nakajima. The prognostic significance of overexpression of the decoy receptor for Fas ligand (DcR3) in patients with gastric carcinomas[J] 2002,Gastric Cancer(2):61~68
  • 7Wenzhu Li,Changgong Zhang,Caixia Chen,Guohong Zhuang.Correlation between Expression of DcR3 on Tumor Cells and Sensitivity to FasL[J].Cellular & Molecular Immunology,2007,4(6):455-460. 被引量:20

共引文献3

同被引文献94

  • 1刘瑞振,张长弓,何琼,苏金华,陈彩霞,陈福,庄国洪.抗人DcR3单克隆抗体的制备、鉴定及应用[J].免疫学杂志,2009(1):34-38. 被引量:8
  • 2何春年,刘贵香,翟金萍,徐翠清,赵焕芬,孙金海.子宫颈鳞癌组织中T、B、NK淋巴细胞浸润与肿瘤免疫[J].免疫学杂志,2005,21(B06):115-118. 被引量:4
  • 3陈莉,李德春,朱远源.NET-1蛋白表达与肝癌临床病理因素相关性探讨[J].中华病理学杂志,2005,34(9):596-597. 被引量:23
  • 4张小燕,卞美璐,房青,陈庆云,陈志华,徐梅.保妇康栓对人乳头状瘤病毒抑制作用的实验研究[J].中日友好医院学报,2007,21(4):216-219. 被引量:63
  • 5Hall M, Rustin G. Recurrent ovarian cancer: when and how to treat [J]. Curr Oncol Rep, 2011, 13(6) : 459 -471.
  • 6Tang L, Yang J, Ng S K, et al. Autoantibody profiling to identify bio- markers of key pathogenic pathways in mucinous ovarian cancer [ J ]. Eur J Cancer, 2010, 46( 1 ) : 170 - 179.
  • 7Hanahan D, Weinberg R A, et al. Hallmarks of cancer: the next gen- eration[J]. Cell, 2011, 144(5): 646-674.
  • 8Femando H S, Sanders A J, Kynaston H G, et al. WAVE1 is associat- ed with invasiveness and growth of prostate cancer cells [ J ]. J Urol, 2008, 180(4): 1515-1521.
  • 9Yang M H, Zhao M Y, Wang Z, et al. WAVE1 regulates P-glycopro- rein expression via Ezrin in leukemia cells [ J ]. Leuk Lymphoma, 2011, 52(2) : 298 - 309.
  • 10Kang R, Tang D, Yu Y, et al. WAVE1 regulates Bcl-2 localization and phosphorylation in leukemia ceils[ J]. Leukemia, 2010, 24( 1 ) : 177 - 186.

引证文献10

二级引证文献35

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部